Form 13F-HR SPHERA FUNDS MANAGEMENT For: Mar 31
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
The Securities and Exchange Commission has not necessarily reviewed
the information in this filing and has not determined if it is
accurate and complete.
| |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F COVER PAGE |
|
Report for the Calendar Year or Quarter Ended: | 03-31-2022 |
Check here if Amendment | Amendment Number: | ||
This Amendment (Check only one.): | is a restatement. | ||
adds new holdings entries. |
Institutional Investment Manager Filing this Report: | |
Name: | SPHERA FUNDS MANAGEMENT LTD. |
Address: | 21 HA'ARBA'AH STREET |
TEL AVIV , L364739 | |
Form 13F File Number: | 028-15863 |
The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.
Person Signing this Report on Behalf of Reporting Manager: | ||||
Name: | Israel Mor | |||
Title: | Partner | |||
Phone: | 972 3 6845535 | |||
Signature, Place, and Date of Signing: | ||||
Israel Mor | Tel Aviv , L3 | 05-16-2022 | ||
[Signature] | [City, State] | [Date] | ||
Report Type (Check only one.): | |
X | 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) |
13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) | |
13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) |
Form 13F Summary Page | |||||
Report Summary: | |||||
Number of Other Included Managers: | 3 | ||||
Form 13F Information Table Entry Total: | 66 | ||||
Form 13F Information Table Value Total: | 707,568 | ||||
(thousands) | |||||
List of Other Managers Reporting for this Manager:
[If there are no entries in this list, omit this section.] | |||
Form 13F File Number | Name | ||
028-15865 | Sphera Global Healthcare Management LP | ||
028-15864 | Sphera Global Healthcare GP Ltd. | ||
028-21415 | Sphera Healthcare US Inc. |
List of Other Included Managers: | |||
Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. | |||
[If there are no entries in this list, state “NONE” and omit the column headings and list entries.] | |||
No. | Form 13F File Number | Name | |
1 | 028-15865 | Sphera Global Healthcare Management LP | |
2 | 028-15864 | Sphera Global Healthcare GP Ltd. | |
3 | 028-21415 | Sphera Healthcare US Inc. |
The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABBVIE INC | COM | 00287Y109 | 30,962 | 190,994 | SH | DFND | 1,2,3 | 190,994 | 0 | 0 | |
ADVANCED MICRO DEVICES INC | COM | 007903107 | 10,934 | 100,000 | SH | DFND | 100,000 | 0 | 0 | ||
AIRBNB INC | COM CL A | 009066101 | 5,153 | 30,000 | SH | DFND | 30,000 | 0 | 0 | ||
AIRBNB INC | CALL | 009066901 | 4,174 | 24,300 | SH | Call | DFND | 0 | 0 | 24,300 | |
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 4,044 | 24,768 | SH | DFND | 1,2,3 | 24,768 | 0 | 0 | |
ALTIMMUNE INC | COM NEW | 02155H200 | 7,959 | 1,306,953 | SH | DFND | 1,2,3 | 1,306,953 | 0 | 0 | |
ARBE ROBOTICS LTD | ORDINARY SHARES | M1R95N100 | 300 | 43,165 | SH | DFND | 43,165 | 0 | 0 | ||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 3,113 | 26,529 | SH | DFND | 1,2,3 | 26,529 | 0 | 0 | |
ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 55,514 | 836,817 | SH | DFND | 1,2,3 | 836,817 | 0 | 0 | |
AYALA PHARMACEUTICALS INC | COM | 05465V108 | 995 | 250,000 | SH | DFND | 1,2,3 | 250,000 | 0 | 0 | |
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 16,293 | 211,326 | SH | DFND | 1,2,3 | 211,326 | 0 | 0 | |
C4 THERAPEUTICS INC | COM STK | 12529R107 | 8,795 | 362,528 | SH | DFND | 1,2,3 | 362,528 | 0 | 0 | |
CAESARSTONE LTD | ORD SHS | M20598104 | 4,503 | 428,046 | SH | DFND | 428,046 | 0 | 0 | ||
CATERPILLAR INC | COM | 149123101 | 2,674 | 12,000 | SH | DFND | 12,000 | 0 | 0 | ||
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 8,077 | 493,677 | SH | DFND | 1,2,3 | 493,677 | 0 | 0 | |
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 11,457 | 521,947 | SH | DFND | 1,2,3 | 521,947 | 0 | 0 | |
CYCLACEL PHARMACEUTICALS INC | COM | 23254L603 | 1,550 | 508,322 | SH | DFND | 1,2,3 | 508,322 | 0 | 0 | |
FATE THERAPEUTICS INC | COM | 31189P102 | 3,467 | 89,425 | SH | DFND | 1,2,3 | 89,425 | 0 | 0 | |
FIVE9 INC | COM | 338307101 | 3,279 | 29,699 | SH | DFND | 29,699 | 0 | 0 | ||
FIVE9 INC | CALL | 338307101 | 27,479 | 248,900 | SH | Call | DFND | 0 | 0 | 248,900 | |
FIVERR INTL LTD | NOTE 11/0 | 33835LAA3 | 4,227 | 4,951,000 | SH | DFND | 4,951,000 | 0 | 0 | ||
GENERAC HLDGS INC | COM | 368736104 | 12,548 | 42,211 | SH | DFND | 42,211 | 0 | 0 | ||
IMMATICS N.V | *W EXP 07/01/202 | N44445117 | 175 | 100,000 | SH | DFND | 1,2,3 | 100,000 | 0 | 0 | |
IMMATICS N.V | SHS | N44445109 | 4,969 | 621,925 | SH | DFND | 1,2,3 | 621,925 | 0 | 0 | |
IMMUNIC INC | COM | 4525EP101 | 6,590 | 583,206 | SH | DFND | 1,2,3 | 583,206 | 0 | 0 | |
INVESCO QQQ TR | PUT | 46090E103 | 45,680 | 126,000 | SH | Put | DFND | 126,000 | 0 | 0 | |
IRONSOURCE LTD | CL A ORD SHS | M5R75Y101 | 2,976 | 620,000 | SH | DFND | 620,000 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 13,029 | 774,130 | SH | DFND | 1,2,3 | 774,130 | 0 | 0 | |
JOHNSON & JOHNSON | COM | 478160104 | 52,287 | 295,023 | SH | DFND | 1,2,3 | 295,023 | 0 | 0 | |
KEROS THERAPEUTICS INC | COM | 492327101 | 7,590 | 139,581 | SH | DFND | 1,2,3 | 139,581 | 0 | 0 | |
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 3,118 | 187,599 | SH | DFND | 1,2,3 | 187,599 | 0 | 0 | |
KRYSTAL BIOTECH INC | COM | 501147102 | 1,684 | 25,310 | SH | DFND | 1,2,3 | 25,310 | 0 | 0 | |
KURA ONCOLOGY INC | COM | 50127T109 | 9,941 | 618,244 | SH | DFND | 1,2,3 | 618,244 | 0 | 0 | |
KYMERA THERAPEUTICS INC | COM | 501575104 | 15,576 | 368,061 | SH | DFND | 1,2,3 | 368,061 | 0 | 0 | |
LIANBIO | SPONSORED ADS | 53000N108 | 1,020 | 275,007 | SH | DFND | 1,2,3 | 275,007 | 0 | 0 | |
LILLY ELI & CO | COM | 532457108 | 20,130 | 70,295 | SH | DFND | 1,2,3 | 70,295 | 0 | 0 | |
MAGIC SOFTWARE ENTERPRISES L | ORD | 559166103 | 1,401 | 81,293 | SH | DFND | 81,293 | 0 | 0 | ||
MASTERCARD INCORPORATED | CL A | 57636Q104 | 4,324 | 12,100 | SH | DFND | 12,100 | 0 | 0 | ||
MERCK & CO INC | COM | 58933Y105 | 22,826 | 278,200 | SH | DFND | 1,2,3 | 278,200 | 0 | 0 | |
MERUS N V | COM | N5749R100 | 10,818 | 409,141 | SH | DFND | 1,2,3 | 409,141 | 0 | 0 | |
NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | 3,646 | 840,000 | SH | DFND | 1,2,3 | 840,000 | 0 | 0 | |
NICE SYS INC | NOTE 1.250% 1/1 | 65366HAB9 | 662 | 250,000 | SH | DFND | 250,000 | 0 | 0 | ||
NOVO-NORDISK A S | ADR | 670100205 | 26,363 | 237,400 | SH | DFND | 1,2,3 | 237,400 | 0 | 0 | |
ONCORUS INC | COM | 68236R103 | 962 | 540,258 | SH | DFND | 1,2,3 | 540,258 | 0 | 0 | |
OTONOMO TECHNOLOGIES LTD | ORDINARY SHARES | M7571L103 | 772 | 391,863 | SH | DFND | 391,863 | 0 | 0 | ||
OUTBRAIN INC | COM | 69002R103 | 564 | 52,531 | SH | DFND | 52,531 | 0 | 0 | ||
PERION NETWORK LTD | SHS NEW | M78673114 | 6,883 | 306,051 | SH | DFND | 306,051 | 0 | 0 | ||
PFIZER INC | COM | 717081103 | 26,665 | 515,070 | SH | DFND | 1,2,3 | 515,070 | 0 | 0 | |
RELMADA THERAPEUTICS INC | COM | 75955J402 | 7,861 | 291,252 | SH | DFND | 1,2,3 | 291,252 | 0 | 0 | |
REPLIMUNE GROUP INC | COM | 76029N106 | 3,611 | 212,640 | SH | DFND | 1,2,3 | 212,640 | 0 | 0 | |
SANOFI | SPONSORED ADR | 80105N105 | 49,924 | 972,415 | SH | DFND | 1,2,3 | 972,415 | 0 | 0 | |
SENTINELONE INC | CL A | 81730H109 | 2,518 | 65,000 | SH | DFND | 65,000 | 0 | 0 | ||
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 25,964 | 460,025 | SH | DFND | 1,2,3 | 460,025 | 0 | 0 | |
SPRINGWORKS THERAPEUTICS INC | CALL | 85205L107 | 7,055 | 125,000 | SH | Call | DFND | 1,2,3 | 0 | 0 | 125,000 |
SUNRUN INC | COM | 86771W105 | 4,556 | 150,000 | SH | DFND | 150,000 | 0 | 0 | ||
SUNRUN INC | CALL | 86771W105 | 6,924 | 228,000 | SH | Call | DFND | 0 | 0 | 228,000 | |
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 22,201 | 1,277,413 | SH | DFND | 1,2,3 | 1,277,413 | 0 | 0 | |
TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | 881624209 | 7,821 | 832,878 | SH | DFND | 832,878 | 0 | 0 | ||
TEVA PHARMACEUTICAL INDS LTD | CALL | 881624209 | 17,747 | 1,890,000 | SH | Call | DFND | 0 | 0 | 1,890,000 | |
TEVA PHARMACEUTICAL INDS LTD | PUT | 881624209 | 1,972 | 210,000 | SH | Put | DFND | 210,000 | 0 | 0 | |
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 3,325 | 666,339 | SH | DFND | 1,2,3 | 666,339 | 0 | 0 | |
VINCERX PHARMA INC | COM NEW | 92731L106 | 2,881 | 720,161 | SH | DFND | 1,2,3 | 720,161 | 0 | 0 | |
VISA INC | COM CL A | 92826C839 | 5,589 | 25,200 | SH | DFND | 25,200 | 0 | 0 | ||
VISTAGEN THERAPEUTICS INC | COM NEW | 92840H202 | 6,140 | 4,951,423 | SH | DFND | 1,2,3 | 4,951,423 | 0 | 0 | |
WEREWOLF THERAPEUTICS INC | COM | 95075A107 | 2,570 | 584,203 | SH | DFND | 1,2,3 | 584,203 | 0 | 0 | |
ZIM INTEGRATED SHIPPING SERV | SHS | M9T951109 | 10,761 | 148,000 | SH | DFND | 148,000 | 0 | 0 |
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ASPINA Announces AMR Solutions
- Kayne Anderson NextGen Energy & Infrastructure Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios at June 30, 2022
- Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios at June 30, 2022
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!